The governance of the pCPA is as follows:

  • Provincial and Territorial Deputy Ministers of Health
    • Responsible for the initiatives of the pCPA.
  • Board of Directors
    • Represented by each individual responsible for the drug plan in their jurisdiction.
    • Responsible for governance functions, engage in knowledge sharing on jurisdictional priorities, issues and concerns that impact the Canadian health system, identify and direct initiatives that require collective leadership and action.
  • Audit and Finance Committee
    • Review and support the financial affairs of the pCPA, including policies the annual budget and financial statements.
  • CEO Evaluation and Succession Planning Committee
    • Develop and oversee the Chief Executive Officer (CEO) evaluation process for the Board.
  • Governance Committee
    • Ensure the efficient and effective governance of the pCPA, including the strategic direction of the pCPA.
  • Negotiations and Policy Committee
    • Composed of operational leaders for each jurisdiction.
    • Oversee and manage the negotiation process for the pCPA and provide policy advice, development and review to the Board.

Members of the Board of Directors


To be confirmed

British Columbia

Mitch Moneo, Assistant Deputy Minister (Chair)


Robert Shaffer, Assistant Deputy Minister (Vice-chair)

New Brunswick

Eric Levesque, Associate Deputy Minister

Newfoundland & Labrador

Pam Barnes, Director, Drug Programs and Services

Northwest Territories

Luke Spooner, Senior Project Manager

Nova Scotia

To be confirmed


Carmine Nieuwstraten, Executive Pharmacy Lead


Patrick Dicerni, Assistant Deputy Minister

Prince Edward Island

Marsha Cusack, Senior Manager, Pharmaceutical Services


Dominic Bélanger, Director, Drug and Pharmaceutical Services


Greg Gettle, Assistant Deputy Minister


Cathy McNeil, Assistant Deputy Minister


Scott Doidge, Director General